New monitor tested to help kidney transplant patients control diabetes
NCT ID NCT07271433
Summary
This study tested whether using a continuous glucose monitor (CGM) could help people with type 2 diabetes better manage their blood sugar after a kidney transplant. Twenty patients wore the monitor for three months while following their standard post-transplant care. Researchers wanted to see if better glucose control could reduce hospital readmissions and improve the health of the new kidney.
This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes NO responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for KIDNEY TRANSPLANT are added.
By submitting, you agree to our Terms of use
Contacts and locations
Show contact details
Enter your email to view the contact information for this study.
By submitting, you agree to our Terms of use
Locations
-
The Cleveland Clinic Foundation
Cleveland, Ohio, 44195, United States
Conditions
Explore the condition pages connected to this study.